Maria A. Martinez-Mane

Tarragona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study.

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study.

Journal: Frontiers in neurology

Published: February 21, 2025

Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

Journal: Frontiers in immunology

Published: November 26, 2024

Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.

Journal: Frontiers in immunology

Published: August 14, 2024

Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab.

Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab.

Journal: Journal of personalized medicine

Published: November 02, 2021

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: October 07, 2017

Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis.

Leukocyte adhesion molecule dynamics after Natalizumab withdrawal in Multiple Sclerosis.

Journal: Clinical immunology (Orlando, Fla.)

Published: March 28, 2016

Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.

Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.

Journal: Journal of neuroimmunology

Published: February 12, 2016

Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.

Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.

Journal: Journal of neurology

Published: December 14, 2015

MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.

MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.

Journal: Journal of neuroimmunology

Published: October 27, 2015

Effectiveness of natalizumab in patients with highly active relapsing remitting multiple sclerosis.

Effectiveness of natalizumab in patients with highly active relapsing remitting multiple sclerosis.

Journal: European neurology

Published: December 19, 2014

Etiologic spectrum and prognosis of longitudinally extensive transverse myelopathies.

Etiologic spectrum and prognosis of longitudinally extensive transverse myelopathies.

Journal: European neurology

Published: October 18, 2013

Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series.

Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series.

Journal: BMC neurology

Published: March 26, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026